Theme: Outstanding Scientific Developments and Treatment Strategies for Thyroid Disorders

Thyroid 2016

Thyroid 2016

Omics International Conferences Invites all the participants from over the world to attend the “International Conference on Thyroid Disorders and Treatment” going to be held in Philadelphia, USA from 29 February to 02 March. The conference includes prompt Keynote Presentations, Oral Talks, Poster Presentation and Exhibitions.

Thyroid 2016 is an international platform for presenting research about Thyroid Disorders and Treatment, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. We welcome all the Academic Scientists, Leading Endocrinologists, Surgeons, Oncologists, General Physicians, Dieticians, Primary Health care specialists, Internists, Pharmaceutical Industrial Delegates, talented young scientists, and student communities across the globe to attend the conference.

Track 1: Thyroid Pathophysiology

Thyroid hormones i.e., activities of T4 and T3 are produced by the follicular cells of the thyroid gland and are regulated by TRH & TSH synthesis made by the thyrotropes of the anterior pituitary gland. The effects of T4 in vivo are mediated via T3 (T4 is converted to T3 in target tissues).Proteases digest iodinated thyroglobulin by Thyroglobulin synthesis, releasing the hormones T4 and T3. The biologically active agents for mechanism of transcriptional regulation, leading to increase the production and plays a major role of thyroid-stimulating hormone, which causes the thyroid to enlarge for the regulation of Thyroid hormone receptors gene expression by binding to hormone response elements (HREs) in DNA either as monomers, heterodimers with retinoid X receptor. Thyroid hormones will also effects on Nutrient Sources and also effects on organ systems. 

Related Conferences: 6th International Conference and Exhibition on Metabolomics, November 28-30 2016, USA; International Conference on Metabolic Syndromes, October 20-22 2016, UAE; 2nd Global Summit on Hormones and Steroids, June 23-25 2016, USA; Global Summit and Expo on Healthcare, November 09-11 2015, UAE; 3rd International Conference on Endocrinology, November 02-04 2015, USA; Epigenetics, Obesity and metabolism, October11- 15 2015, UK; Canadian Society of Endocrinology and Metabolism Professional Conference and Annual Meeting, November 30- December 03 2015, Canada; 11th  National Congress on Spanish Association for the Study of Inborn Errors of Metabolism, October 14-16 2015, Spain; 15th international thyroid congress, October 18-23 2015, USA; Lipid Update 2015, November 26-27 2015, UK; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 2: Thyroid: Diagnosis and Clinical Evaluation

TSH tests, Blood tests and other test to measure thyroid function are readily available and widely used. To understand a test's scientific basis and what it can tell us, a quick review of the thyroid glands pathophysiology is in order. The Thyroid test and TRH stimulation test is the best initial test of thyroid function. In clinical practice, three basic scenarios indicate a need for laboratory and statistical analysis of thyroid function: (1) suspicion of thyroid disease based on clinical signs and symptoms (2) Thyroid scan and imaging (3) evaluation of treatment for thyroid disease. 

Related Conferences: International Conference and Exhibition on Dual Diagnosis, July 21-22 2016, USA; International conference on Medical Imaging & Diagnosis, May 09-10 2016, USA; 13th Global Diabetes Conference & Medicare expo, August 08-10 2016, UK; Global Summit and Expo on Healthcare, November 09-11 2015, UAE; International conference on Internal Medicine, November 03-05 2016, USA;  Mena Women’s Health Congress, November 5-7 2015, UAE; Optimising Prostate Cancer Diagnostics, September 29-30 2015, UK; 3rd Clinical Congress on Gulf Chapter of the American Association of Clinical Endocrinologists, October 29-31 2015, UAE; Society for Endocrinology BES, November 02-04 2015, UK; Medicine Update, November 06-07 2015, South Africa; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE

Track 3: Thyroid: Clinical Studies Cases Reports

A medical case report is generally considered a type of anecdotal evidence. Given their intrinsic methodological limitations, including lack of statistical sampling, case reports are placed at the foot of the hierarchy of clinical evidence, together with case series for the clinical reviews. Nevertheless, case reports do have genuinely useful roles in medical research and evidence-based medicine. In particular, they have facilitated recognition of new diseases like Thyroid and adverse effects of treatments. Case reports have role diseases. They can also help understand the clinical spectrum of rare diseases, as well as unusual presentations of common diseases. They can help generate study hypotheses, including plausible mechanisms. Case reports may also have a role to play in guiding the personalization of disorders and treatments in clinical practice. 

Related Conferences: International Conference on Case reports, March 31-April 02 2016, Spain; 3rd Experts Meeting on Medical Case Reports, May 09-11 2016, USA; 8th Euro Global Diabetes Summit and Medicare Expo: November 03-05 2015, Spain; International conference on Internal Medicine, November 03-05 2016, USA; 6th Global Diabetes Summit and Medicare Expo, November 02-04 2015, UAE;  Mena Women’s Health Congress, November 5-7 2015, UAE; 32nd National Congress on French Society of Endocrinology, October 7-10 2015, France; Swiss Society of Endocrinology and Diabetology Annual Meeting 2015, November 12-13 2015, Switzerland; The Economist's Health care Forum: War on Cancer, September 29 2015, USA; 26th Annual National Conference on Women’s health Care, September 17-19 2015, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Track 4: Thyroid: Nutrition & Supplements

The thyroid gland needs specific vitamins and minerals to properly do its job. Since we are all unique in how our hormones are functioning, the best way to get a handle on what our body specifically needs is to have a full thyroid panel done to help pinpoint where individual levels may be off balance. Research shows us that there are a few key nutrients that are highly valuable for everyone. Some nutrients heavily influence the function of the thyroid gland, and certain foods can inhibit your body's ability to absorb the replacement hormones you may take as part of your thyroid treatment. There's no such thing as a "hypothyroidism diet" that will make you well, but eating smart can help you feel better despite the condition. There are many ways to support thyroid health easily and naturally, utilizing food and nutrients to encourage proper functioning. The way we eat can actually help, or hurt, our thyroid gland. The nutrients our thyroid needs are easily accessible in many foods and dietary supplements. With the right information, we can make simple choices to improve thyroid health. 

Related Conferences: 4th International Conference and Exhibition on Nutrition, October 26-28 2015, USA; 7th Health care and Fitness Summit, September 26-28 2016, UK; 4th International Conference on weight Loss and Fitness Expo, November 21-23 2016, UAE; 5th International Conference on Clinical Nutrition, November 28-30 2016, USA; 4th International Conference and Exhibition on Obesity and Weight Management, December 07-09 2016, USA; 15th International Nutrition & Diagnostics Conference, October 05-08 2015, Czech Republic; 9th Diets-European Federation of the Associations of Dietitians Conference, October 23-24 2015, Netherlands; Epigenetics, obesity and Metabolism, October 11-14 2015, UK; 56th Annual Conference on American College of Nutrition’s , November 11-14 2015, USA; British Society of Paediatric Gastroenterology, Hepatology and Nutrition Annual Winter Meeting, January 27-29 2016, UK; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 5: Thyroid Cancer: Treatment & Therapy

Thyroid cancer is a cancer originating from follicular or Para follicular thyroid cells. Most often the first symptom and risk factors of thyroid cancer is a nodule in the thyroid region of the neck. However, many adults have small nodules in their thyroids, but typically fewer than 5% of these nodules are found to be cancerous. Papillary, Follicular and Medullary Thyroid cancer are the types of the Thyroid cancer. Thyroidectomy and dissection of central neck compartment is initial step in Treatment of Thyroid cancer in majority of cases. The prognosis and types of standard treatment options of thyroid cancer is related to the type of cancer and the stages of Thyroid Cancer at the time of diagnosis.

Related Conferences: 9th Indo Global Summit on Cancer Therapy, November 02-04 2015, India; 8th Euro Global Summit on Cancer Therapy, November 03-05 2015, Spain; 2nd Global Summit on Hormones and Steroids, June 23-25 2016, USA; 3rd International Conference on Endocrinology, November 02-04 2015, USA; 8th Euro Global Diabetes Summit and Medicare Expo, November 03-05 2015, Spain; 18th ECCO-40th ESMO European Cancer Congress, September 25-29 2015, Austria; The Economist's Health care Forum, September 29 2015: War on Cancer 2015, USA; Optimising Prostate Cancer Diagnostics, September 29-30 2015, UK; 18th Russian Cancer Congress, November 17-19 2015, Russia ; Medicine Update, November 06-07 2015, South Africa; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE

Track 6: Parathyroid: Treatment & Therapy

Parathyroid disease is conventionally divided into states where Hyperparathyroidism (parathyroid Disease and Hyperthyroidism). A large proportion of patients have “biochemical” hyperparathyroidism but with prolonged follow up they progress to overt clinical presentation. Resection of the parathyroid lesion is curative with recurrences observed mainly in the multiple glandular diseases. Parathyroid glands are no different than every other tissue in the human body--they can develop cancer in them. Parathyroid cancer, however, is extremely rare. Surgery is the most common for Parathyroid Tumours and by far the best treatment for parathyroid cancer. Diagnosis & Treatment for parathyroid cancer depends on the size of the tumour, its location, and whether or not it has spread to other tissues.

Related Conferences: 3rd International Conference on Endocrinology, November 02-04 2015, USA; 8th Euro Global Diabetes Summit and Medicare Expo: November 03-05 2015, Spain; Indo-Global Summit & Expo on Healthcare, October 05-07 2015, India; 7th Health care and Fitness Summit, September 26-28 2016, UK; 2nd Global Summit on Hormones and Steroids, June 23-25 2016, USA; American Thyroid Association International Thyroid Congress, October 18-23 2015, USA; 15th international thyroid congress, October 18-23 2015, USA; 42nd Annual  UC Davis Diabetes and Endocrinology Symposium, March 18-19 2016, USA; 3rd Clinical Congress on Gulf Chapter of the American Association of Clinical Endocrinologists, October 29-31 2015, UAE; European Society for Paediatric Endocrinology, October 1-03 2015, Spain; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Track 7: Thyroid Disorders: In Children, Teens and Adolescents

Other symptoms such as behaviour changes, changes in school performance, and persistent belly pain may also be present. When the thyroid gland produces too much thyroid hormone (overactive), the condition is called hyperthyroidism. When the thyroid gland produces too little thyroid hormone (underactive), the condition is called hypothyroidism. Thyroid hormone can also lead to   Hypothyroidism in new born. Women are more likely than men to have thyroid disease. One in eight women will develop thyroid problems during her lifetime. For example, women are at particularly high risk for developing thyroid disorders following Infertility, Miscarriage & Complications during pregnancy & childbirth. In women, thyroid diseases can cause problems with your menstrual period, Problems getting pregnant, Problems during pregnancy. Postpartum thyroiditis is a syndrome of thyroid dysfunction occurring within the first 12 months of delivery as a consequence of the postpartum immunological rebound that follows the immune tolerant state of pregnancy. Still, the overall lack of evidence precludes a recommendation for universal screening for thyroid disorder during pregnancy.

Related Conferences: Annual Pediatric Emergency Medicine Conference, March 29-31 2016, USA; International Conference and Exhibition on Pediatric Oncology, August 04-06 2016, Canada; Indo-Global Summit & Expo on Healthcare, October 05-07 2015, India; 2nd International Conference on Gynecology & Obstetrics, November 16-18 2015, USA; 6th Global Diabetes Summit and Medicare Expo, November 02-04 2015, UAE; European Society for Paediatric Endocrinology, October 1-03 2015, Spain; 26th Annual National Conference on Women’s health Care, September 17-19 2015, USA; Mena Women’s Health Congress, November 5-7 2015, UAE; 7th Health care and Fitness Summit, September 26-28 2016, UK; 32nd National Congress on French Society of Endocrinology, October 7-10 2015, France; Endocrinology Conferences October 10-12, 2016 Manchester, ; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 8: Thyroid Surgery & Care

The most common reason for thyroid surgery is the presence of nodules or tumours on the thyroid gland. Most of these thyroid nodules are benign but some are cancerous or pre-cancerous. There are several different types of hormone surgery. The most common are lobectomy, subtotal thyroidectomy, and total thyroidectomy. Thyroid surgery is used for thyroid nodule surgery, Thyroid Surgery for cancer and goitre, and Thymectomy (Surgery to remove thymus. Perfect care should be taken for the recovery after Surgery.

Related Conferences: Global Summit and Medicare Expo on Head & Neck Surgery, November 30- December 01 2015, USA; 4th International Conference and Exhibition on Surgery, October 05-07 2015, UAE; Specialists Meeting on Ear, Nose and Throat Disorders, November 03-05 2016, Spain; Medicine Update, November 06-07 2015, South Africa; 3rd International Conference on Endocrinology, November 02-04 2015, USA; 41st Annual Conference on Indian Association of Pediatric Surgeons, October 01-04 2015, India; American Academy of Otothinolaymgology Head and Neck Surgery, September 27-30 2015, USA; 3rd Clinical Congress on Gulf Chapter of the American Association of Clinical Endocrinologists, October 29-31 2015, UAE; Society for Endocrinology BES, November 02-04 2015, UK; Medicine Update, November 06-07 2015, South Africa; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE

Track 9: Thyroid Challenges & Improvements

The metabolism of T3 and T4 combination therapy into active and inactive intermediates involves the action of 3 types of deiodinases. Recent studies of common genetic variations in deiodinase and thyroid hormone transport proteins offer fresh insights in understanding the variable response to thyroid hormone therapy and future research may clarify whether subsets of patients will benefit from challenges and improvements to combination therapy. Despite significant challenges, opportunities abound for improving the Thyroid Treatment Augments Psychiatric Therapy and also Improvements of Reproductive, Neuro-endocrinology or Neuroendocrine Function in Hypothalamic.

Related Conferences: 3rd International Conference on Endocrinology, November 02-04 2015, USA; 8th Euro Global Diabetes Summit and Medicare Expo: November 03-05 2015, Spain; 9th Global Diabetologists Annual Meeting and Medicare Expo, June 06-08 2016, USA; 4th International Conference on weight Loss and Fitness Expo, November 21-23 2016, UAE; 2nd International Conference on Gynecology & Obstetrics, November 16-18 2015, USA;  11th  National Congress on Spanish Association for the Study of Inborn Errors of Metabolism, October 14-16 2015, Spain; 15th international thyroid congress, October 18-23 2015, USA; ; 32nd National Congress on French Society of Endocrinology, October 7-10 2015, France; The Economist's Health care Forum, September 29 2015: War on Cancer 2015, USA; Optimising Prostate Cancer Diagnostics, September 29-30 2015, UK; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Track 10: Thyroid Therapy: Medications & Remedies

Thyroid replacement hormones are Novel Thyroid medications used to treat hypothyroidism, a condition in which the production of thyroid hormone in the body is abnormally low. Thyroid hormones increase cellular metabolism (activity of cells) that is responsible for Understanding Thyroid function, Dietary & Lifestyle changes and several other cellular processes. Low levels of thyroid hormones in the body can result in many problems given the numerous activities that they mediate. Purpose of Thyroid Hormone Therapy is to remove the gland, found in the lower neck is responsible for the production of thyroid hormones. Natural Thyroid Medication Treatment and supplements are used for the therapy.

Related Conferences: 9th Indo Global Summit on Cancer Therapy, November 02-04 2015, India; 8th Euro Global Summit on Cancer Therapy, November 03-05 2015, Spain; 2nd Global Summit on Hormones and Steroids, June 23-25 2016, USA; International Conference on Metabolic Syndromes, October 20-22 2016, UAE; 4th International Conference and Exhibition on Obesity and Weight Management, December 07-09 2016, USA; 15th international thyroid congress, October 18-23 2015, USA; Lipid Update 2015, November 26-27 2015, UK; Epigenetics, obesity and Metabolism, October 11-14 2015, UK; 56th Annual Conference on American College of Nutrition’s , November 11-14 2015, USA; British Society of Paediatric Gastroenterology, Hepatology and Nutrition Annual Winter Meeting, January 27-29 2016, UK; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Omics International Conferences Invites all the participants from over the world to attend the “International Conference on Thyroid Disorders and Treatment” going to be held in Philadelphia, USA from 29 February to 01 March. The conference includes prompt Keynote Presentations, Oral Talks, Poster Presentation and Exhibitions.

Thyroid 2016 is an international platform for presenting research about Thyroid Disorders and Treatment, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. Conference is comprised of 10 tracks designed to offer sessions including Hyper and Hypothyroidism- Treatment strategies, Thyroid Cancer & Surgery, Iodine Metabolism, Drug and Hormonal Therapy, Prevention, Production & Regulation of Thyroid Hormone, Disorders of the Parathyroid & Treatment, Thyroid Cancer & Treatment, Women Thyroid-Effects on Reproductive Health & Pregnancy, Diagnosis and Clinical Evaluation of Thyroid Disease, Thyroid in Children, Teens and Adolescents, Thyroid Metabolism and Iodine Uptake, Thyroid Hormone Therapy , Medications and Remedies, Thyroid Surgery- Challenges & Complexities of Thyroid Hormone Replacement, Natural supplements, Dietary solutions and other Alternative Treatment approaches enhancing new research in Thyroid Disease TreatmentThyroid 2016 is an international platform for presenting research about Thyroid Disorders and Treatment, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. We welcome all the Academic Scientists, Leading Endocrinologists, Surgeons, Oncologists, General Physicians, Dieticians, Primary Health care specialists, Internists, Pharmaceutical Industrial Delegates, talented young scientists, and student communities across the globe to attend the conference.We are confident that “Thyroid 2016” conference would emerge as one of the best scientific conferences organized by OMICS International in 2016. 

One in eight women will develop a thyroid disorder during her lifetime. And, the number of people suffering from thyroid disorders continues to rise each year. But the bigger problem is that nearly 60% of these people are completely unaware of their condition let alone how to heal it. Millions of people are suffering trying all kinds of diets, pills, and treatments to clear their mental fog, to boost energy and lose weight. Unfortunately, they will all fail unless they learn how to heal the underlying thyroid issues.

Why to attend???

Medical doctors, patients and health care providers consider the prevention of Thyroid diseases as an essential tool to improve the general health status of the population. The proportions of people suffering from the disease are expected to increase in future according a recent statistical survey. Realizing this imperative, OMICS Group is set to organize International Conference on Thyroid Disorders and Treatment for the upcoming year with a view to enhance research and promote awareness aiming in developing solutions for the challenges encountered.

Target Audience:

  • Thyroid Students, Scientists
  • Thyroid Researchers
  • Thyroid Faculty
  • Medical Colleges
  • Thyroid Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Manufacturing Medical Devices Companies

Summary: International Conference on Thyroid Disorders and Treatment, going to be held during February 29 – March 02, 2016 at Philadelphia, USA. The Conference will be organized around the theme “Outstanding Scientific Developments and Treatments Strategies for Thyroid Disorders” highlighting the latest and exciting innovations in Thyroid Disease and Treatment. Thyroid 2016 Conference invites all Academic Scientists, Leading Endocrinologists, Surgeons, Oncologists, Radiation Therapists, General Physicians, Dieticians, Primary Health care specialists, Internists, Pharmaceutical Industrial Delegates, talented young scientists, and student communities across the globe to attend Thyroid conference under a single roof where networking and global partnering happens for the acceleration of future research.

For more details please visit- http://thyroid.conferenceseries.com/

Importance & Scope

Number of people suffering from thyroid disorders continues to rise each year.As reported by the World Health Organization (WHO), on an average 1 out of every 13 people more specifically 20 million to 750 million cases are diagnosed globally with thyroid diseases each year. There are more than 250 million cases with hyperthyroidism globally. Around 60% of the populations effected with thyroid disorder are uncaring of the situation. Female population is 5-6 times more likely to develop a thyroid disorder.

Millions of people are suffering and also trying all kinds of diets, pills, and treatments to clear their mental fog, to boost energy and lose weight. Unfortunately, they will all fail unless they learn how to heal the underlying thyroid issues.

Many International Conferences and Diabetic therapies meetings/ symposium and workshops have been organized on different topics related to the risk factors related to diabetes across the globe such as obesity conferences, weight loss conferences, Endocrine Conferences etc.

OMICS International Cordially invites all the Academic Scientists, Leading Endocrinologists, Surgeons, Oncologists, Radiation Therapists, General Physicians, Dieticians, Primary Health care specialists, Internists, Pharmaceutical Industrial Delegates, talented young scientists, and student communities across the globe to attend Thyroid Conference, where all the aspects of Thyroid Disorders and Treatment will be discussed under single roof. Thyroid 2016 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field.  It is open to all types of research methodologies both from academia and industry.

Thyroid 2016 is an international platform for presenting research about Thyroid Disorders and Treatment, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society.

Why Philadelphia (Pennsylvania)?

Thyroid cancer is rising faster in Pennsylvania than in the rest of the United States. Thyroid cancer is now the seventh leading type of cancer in the nation. It typically occurs in young women and is projected to become the third most common cancer in women by 2019. Papillary thyroid cancer, responsible for most of this increase, is very treatable and has a 95 percent 30-year survival rate.

In Pennsylvania, white women had a 25.5 percent rise in thyroid cancer, followed by black women at 17.7 percent; white men at 8 percent; and black men at 3.8 percent. The fastest rate of increase over time occurred in black women. Papillary thyroid cancer had the largest increase in cancer type -- an 8.8 percent yearly change -- followed by anaplastic thyroid cancer at 4.2 percent and follicular thyroid cancer at 1.4 percent. Tumors confined to the thyroid at diagnosis increased 8.5 percent per year, while those that spread regionally outside the tumor increased by 7 percent. The two trends were not parallel, indicating that the greatest increase has been among tumors localized to the thyroid at diagnosis.

Conference Highlights: 

  • Thyroid Pathophysiology
  • Diagnosis and Clinical Evaluation
  • Clinical Studies Case Reports
  • Nutrition & Supplements
  • Thyroid Cancer: Therapy & Treatment
  • Parathyroid: Treatment & Therapy 
  • Thyroid Disorders: In Children, Teens and Adolescents
  • Thyroid Surgery & Care
  • Thyroid Challenges & Improvements
  • Thyroid Therapy: Medications & Remedies

Members Associated with Thyroid Research around the Globe

The American Thyroid Association (ATA) serves as the professional for all the leading researchers and clinicians and also for the people in the field of thyroidology, and provides a rich resource for the public and patients with thyroid disease and thyroid cancer. 1700 members from 43 different countries, working together in the organization of researchers, clinicians, surgeons and other healthcare professionals, to advance the care and treatment of patients with thyroid disease.

Hospitals Associated with Thyroid Research in Philadelphia

  • Jefferson University Hospital
  • The Children’s Hospital of Philadelphia
  • Fox chase Cancer Centre
  • Temple University Hospital

Hospitals Associated with Thyroid Research in USA

  • U-M Comprehensive Cancer Centre’s, USA
  • Endocrine Surgery Thyroid Centre, US
  • University of California San Francisco Medical Centre, California
  • Columbia university Medical Centre, New York
  • Centre for Endocrine surgery, Washington , New York

Hospitals Associated with Thyroid Research in World

  • Thyroid Foundation of Canada
  • Brigham and Women’s Hospital, Boston
  • Thyroid UK, United Kingdom
  • Thyroid Clinic Sydney, Australia
  • Diabetic Thyroid Hormone Centre, Delhi, India
  • King Edward VIII Hospital , Durban , South Africa

Major Thyroid Associations in Philadelphia

  • Major Thyroid Associations in Philadelphia
  • The Jefferson Thyroid and Parathyroid Center
  • The Pediatric Thyroid Center 
  • Fox Chase Thyroid Cancer Center
  • Temple University Hospitals
  • Penn Thyroid Association

Major Thyroid Associations in USA

  • American Thyroid Association
  • Oprah’s Thyroid Club
  • Canary Club
  • University of Pittsburgh’s Medical Centre

Major Thyroid Associations around the Globe

  • European Thyroid Association
  • Asian Association of Endocrine Surgeons
  • British Association of Endocrine & Thyroid Surgeons
  • Indian Thyroid Society
  • Thyroid Society of Canada
  • Thyroid Cancer Survivor’s Association
  • National Thyroid Cancer Institute
  • Australian Thyroid Association
  • Thyroid Association of  New Zealand

Target Audience:

Thyroid 2016 conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of Thyroid under a single roof where networking and global partnering happens for the acceleration of future research. Following are the areas for targeting the audience percentage wise:

Scientists      60%

Academia    40%

Doctors       10%

Top Universities in Philadelphia:

  • Temple University School of Medicine
  • University of Pennsylvania
  • University of the Sciences in Philadelphia
  • Thomas Jefferson University
  • Philadelphia University
  • Weill Cornell Medical College
  • UTMB Health

Top Universities in USA

  • University at Buffalo, State University of New York
  • University of Birmingham
  • University of Anschutz medical campus
  • University of California
  • University of Washington
  • University of Tennessee, Health Science Center
  • University Of California
  • UT Health Science Center

Top Universities in World

  • UCL (University College London)
  • Imperial College London
  • University of Sydney
  • The University of Tokyo
  • National University of Singapore
  • The University of Hong Kong
  • Monash University

Glance at Market of Thyroid:

One in eight women will develop a thyroid disorder during her lifetime. And, the number of people suffering from thyroid disorders continues to rise each year. But the bigger problem is that nearly 60% of these people are completely unaware of their condition let alone how to heal it. Millions of people are suffering trying all kinds of diets, pills, and treatments to clear their mental fog, to boost energy and lose weight. More than 6million people in Philadelphia, 42 million people in the US and 750 million worldwide and have a Thyroid Disorder in the past 10 years. Some estimates are over 20 million in Philadelphia 70 million in US and over  1000 million worldwide, and growing in next 10 years.

About 43,210 cases of new thyroid cancers will be diagnosed in women. The other 13,250 will be found in men. Thyroid cancer rates have risen sharply in recent years and it is the fastest-increasing cancer in both men and women. Thyroid cancer has a 97% survival rate at the five-year mark. This means that out of every 100 people treated for thyroid cancer, 97 of them will be alive five years after treatment. About 1,000 women and 780 men will die of thyroid cancer. Epidemiological data from WHO suggests that there are more than 750 million cases globally with thyroid disorder. 

Market Growth of Thyroid Disease in Past 10 Years

 

Market Growth of Thyroid Disease in Next 10 Years

 

Companies Associated with Thyroid products and their funding

Product

Company

Funding ($ Billion)

Armour Thyroid, Levothroid, Thyrolar

Forest Pharmaceuticals

2.5

Cytomel, Levoxyl, Tapazole

King Pharmaceuticals

1.1

Nature Thyroid

Western Research Laboratories

1.2

Synthroid

Abbott Laboratories

2

Thyrogen

Genzyme Pharmaceuticals

1.7

 

National Institute of Health (NIH) funding for Thyroid

  • Children’s Hospital of Philadelphia (CHP) ,Philadelphia : $125,651,920
  • Thomas Jefferson University (TJU), Philadelphia : $49,662,761
  • Fox Chase Cancer Center (FCCC), Philadelphia : $15,771,776
  • American Association of Cancer Research (AACR), Philadelphia : $768,746
  • Cancer Prevention Institute of California (CPIC), California  : $1,305,376
  • International Agency for Research on Cancer (IARC), Lyon : $371,221

 

 

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date February 29-March 01, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2 Day 3
Poster Opportunity Closed Click Here to View

Media Partners